Lingering CAR T cells may be the cause of serious gut complication after myeloma therapy

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

Patients with multiple myeloma who developed a serious gastrointestinal side effect after treatment with chimeric antigen receptor (CAR) T cell therapy had significantly more CAR T cells persisting in their bloodstream, according to new research from The University of Texas MD Anderson Cancer Center.

Read original article on Medical Xpress - latest medical and health news stories →